Corbus Pharmaceuticals Holdings, Inc. (CRBP)
3.88
-0.04
(-0.89%)
USD |
NASDAQ |
Nov 03, 16:00
3.88
0.00 (0.00%)
After-Hours: 19:48
Corbus Pharmaceuticals Holdings Cash and Short Term Investments (Quarterly) : 117.94M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 117.94M |
| March 31, 2026 | 138.60M |
| December 31, 2025 | 163.94M |
| September 30, 2025 | 104.27M |
| June 30, 2025 | 116.88M |
| March 31, 2025 | 133.07M |
| December 31, 2024 | 149.35M |
| September 30, 2024 | 159.65M |
| June 30, 2024 | 147.31M |
| March 31, 2024 | 120.39M |
| December 31, 2023 | 21.10M |
| September 30, 2023 | 28.93M |
| June 30, 2023 | 36.76M |
| March 31, 2023 | 44.42M |
| December 31, 2022 | 59.39M |
| September 30, 2022 | 66.42M |
| June 30, 2022 | 73.50M |
| March 31, 2022 | 86.31M |
| December 31, 2021 | 97.84M |
| September 30, 2021 | 107.06M |
| June 30, 2021 | 106.55M |
| March 31, 2021 | 124.36M |
| December 31, 2020 | 85.78M |
| September 30, 2020 | 82.22M |
| June 30, 2020 | 63.47M |
| Date | Value |
|---|---|
| March 31, 2020 | 46.62M |
| December 31, 2019 | 31.75M |
| September 30, 2019 | 54.85M |
| June 30, 2019 | 73.15M |
| March 31, 2019 | 89.92M |
| December 31, 2018 | 41.75M |
| September 30, 2018 | 55.66M |
| June 30, 2018 | 64.68M |
| March 31, 2018 | 70.96M |
| December 31, 2017 | 62.70M |
| September 30, 2017 | 36.80M |
| June 30, 2017 | 43.18M |
| March 31, 2017 | 49.08M |
| December 31, 2016 | 15.14M |
| September 30, 2016 | 18.91M |
| June 30, 2016 | 22.02M |
| March 31, 2016 | 9.688M |
| December 31, 2015 | 12.34M |
| September 30, 2015 | 13.17M |
| June 30, 2015 | 9.243M |
| March 31, 2015 | 4.972M |
| December 31, 2014 | 6.262M |
| September 30, 2014 | 7.536M |
| June 30, 2014 | 8.504M |
| March 31, 2014 |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Heron Therapeutics, Inc. | 42.66M |
| Tonix Pharmaceuticals Holding Corp. | 176.23M |
| Karyopharm Therapeutics, Inc. | 65.10M |
| Minerva Neurosciences, Inc. | 75.37M |
| Ocugen, Inc. | 100.05M |